More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
2025 National Association of Medicaid Directors (NAMD) Fall Conference
Join Abt Global at the 2025 National Association of Medicaid Directors (NAMD) Fall Conference.
When the Stakes Are High: Our Take on Client-Centricity at CMS
Abt partners with CMS by listening, anticipating needs, and co-creating solutions that make the agency’s work easier, more efficient, and more impactful.
A Use Case Roadmap for AI-Ready Community Health
A three-step process and scoring matrix help healthcare teams find, refine, and prioritize AI ideas that deliver real, measurable impact.
2025 Association for Public Policy Fall Research Conference (APPAM)
Join Abt Global at the 2025 Association for Public Policy Fall Research Conference (APPAM).